Fabrication and Dosimetric Characteristics of Silicon Elastomer-Based Bolus Using External Beam Radiotherapy.

OBJECTIVE: A study on dosimetric characteristics of silicon elastomer-based bolus was carried out using a Linear accelerator (Varian - Unique Performance). The study is performed to know if the silicone elastomer based bolus can be used in the radiotherapy. A bolus is a tissue equivalent material used to provide uniform dose to the uneven surface contours. It is exposed during the radiation therapy and also provides maximum dose (dmax) to treat surface tumors in case of high energy photons like megavoltage therapy photons. It is used in the case of external beam radiation therapy. METHODS: In this study, the bolus was fabricated using PDMS substrate with a curing agent by the ratio of 10:1. The bolus was fabricated in two thicknesses 0.5cm and 1cm. The dosimetric characteristics like transmission factor, mass attenuation coefficient, durability, homogeneity, density test of the fabricated bolus were studied. RESULTS: The dosimetric characteristics of the silicone elastomer based bolus were studied over a period of one month by exposing it in a 6MV photon. The result of the study shows that the silicone elastomer based bolus fabricated, satisfies the dosimetric characteristics needed for a tissue equivalent bolus to be used in the radiation therapy. CONCLUSIONS: The fabricated bolus could increase the percentage surface dose, reduce skin-sparing effect, and protect OAR. The aim of this is to provide an adjustable, transparent, and easily fabricated, less expensive, nontoxic bolus which can be used in the radiotherapy.

An empirical method for splitting arcs in VMAT.

PURPOSE: We present a new approach to determine the optimal arc split for VMAT beams which is an extension of our recently published algorithm for selecting optimal beam angles in Intensity Modulated Radiation Therapy (IMRT) MATERIAL AND METHODS: The proposed approach uses an objective function based scoring method called "ψ - score" to determine optimal arc splitting strategy. To validate our approach, we applied it in different clinical cases: Abdomen-Para aortic node, Lung, Pancreas and Prostate. Basically, for all clinical cases, two set of plans were created, namely VMAT plan and VMAT_S plan using Pinnacle3 (V16.2, Philips Medical Systems (Cleveland), Inc.). In the VMAT plans, full arc (360°) with 4-degree gantry spacing was used during optimization to compute the "ψ - score". Subsequently the avoidable arc portions were identified and removed using the ψ - score plot followed by the final optimization (VMAT_S). RESULTS: Equivalent or better OAR sparing, and similar target coverage were achieved in VMAT_S plans compared to VMAT plans. VMAT_S reduced the number of control points and monitor units by 24.2% and 12.9% respectively. On the average, beam on time was reduced by 21.9% and low dose volume (5 Gy isodose volume) to healthy tissues was reduced by 4.9% in VMAT_S compared to VMAT plans. CONCLUSION: The results demonstrated that the proposed method is useful for reducing the monitor units, beam on time and low dose volume without significantly compromising plan quality and most useful for non-centrically located targets.

An In-Vitro Study for Early Detection and to Distinguish Breast and Lung Malignancies Using the Pcb Technology Based Nanodosimeter.

Since the early detection of cancer increases the chance of successful treatment, the present study focused to confirm the suitability of an indigenously fabricated multilayer PCB technology based 3D positive ion detector to detect breast and lung malignancy at an early stage. The 3D positive ion detector is a type of gas filled radiation detector works under the principle of ion induced ionization using an exempted micro curie activity source. Earlier studies report that malignant cells can be detected by analyzing the Volatile Organic Compounds (VOCs) exhaled by those cells that serve as eminent biomarkers for malignant detection. Based on this, the present study analyzed the signals produced in the detector by VOCs exhaled from 140 biopsy tissue samples that include tissue of normal and all stages of breast and lung malignancy. To strengthen the present data, the normal and advanced breast and lung malignant tissues were also analyzed using the Gas Chromatography- Mass Spectrometry (GC-MS). From this study, it is confirmed that the present 3D positive ion detector can be used to detect both breast and lung malignancy and also to distinguish them based on the variation in four basic physical parameters of the output pulse such as frequency, amplitude, rise time and fall time and four derived parameters of the pulse such as FWHM, area of the pulse, ionization cluster size, and ion drift time.

Quality Assurance and Average Glandular dose Measurement in Mammography Units.

To ensure the safe operation of mammography units, acceptance tests and quality assurance (QA) protocols have been developed by the American Association of Physicists in Medicine (AAPM), Engineers Registration Board, and International Atomic Energy Agency. Eight mammography units manufactured by five different manufacturers located in hospitals in our region were investigated following the AAPM and Atomic Energy Regulatory Board (AERB) protocols using a solid-state dosimeter-based PTW-NOMEX Multimeter and a metal-oxide-semiconductor field-effect transistor. This study evaluated different operating parameters through mechanical test, accelerating voltage (kVp) accuracy test, machine output measurement, half-value layer measurement, calibration of compression device, image quality assessment, measurement of leakage radiation, radiation survey, and average glandular dose (AGD) measurements using stereotactic needle biopsy phantom. The results show that out of eight mammography units, only a single mammography unit (U-1) passed all QA tests and 2 units passed 7 tests, 2 units passed 6 tests, and 3 units passed 5 tests out of 8 QA tests. In unit 5, the AGD value was 4 and 1.93 mGy before and after service, respectively. QA programs as recommended by AAPM and AERB should be carried out periodically to ensure safety in breast cancer screening. This work points to the importance of the regulation and effective compliance and also help in both improving the QA and reduce the glandular dose received by the patients.

A mathematical approach to beam matching.

OBJECTIVE: This report provides the mathematical commissioning instructions for the evaluation of beam matching between two different linear accelerators. METHODS: Test packages were first obtained including an open beam profile, a wedge beam profile and a depth-dose curve, each from a 10×10 cm(2) beam. From these plots, a spatial error (SE) and a percentage dose error were introduced to form new plots. These three test package curves and the associated error curves were then differentiated in space with respect to dose for a first and second derivative to determine the slope and curvature of each data set. The derivatives, also known as bandwidths, were analysed to determine the level of acceptability for the beam matching test described in this study. RESULTS: The open and wedged beam profiles and depth-dose curve in the build-up region were determined to match within 1% dose error and 1-mm SE at 71.4% and 70.8% for of all points, respectively. For the depth-dose analysis specifically, beam matching was achieved for 96.8% of all points at 1%/1 mm beyond the depth of maximum dose. CONCLUSION: To quantify the beam matching procedure in any clinic, the user needs to merely generate test packages from their reference linear accelerator. It then follows that if the bandwidths are smooth and continuous across the profile and depth, there is greater likelihood of beam matching. Differentiated spatial and percentage variation analysis is appropriate, ideal and accurate for this commissioning process. ADVANCES IN KNOWLEDGE: We report a mathematically rigorous formulation for the qualitative evaluation of beam matching between linear accelerators.

Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.

An analysis of Ir-192 source distribution using the Monte Carlo method and radiochromic film experiments for endovascular brachytherapy is presented. Three different source possibilities, namely, mHDR Ir-192 sources with 5 mm and 2.5 mm step sizes and Ir-192 seed sources with 1 mm air gap are investigated to obtain uniform radial dose distribution throughout the treatment area. From this study, it is inferred that mHDR Ir-192 sources with 2.5 mm step size are effective for getting dose uniformity. Hence, different restenosis geometries, namely, linear, dumb bell and hairpin, are simulated with 2.5 mm step size, 15 mHDR Ir-192 sources using the Monte Carlo technique and the results are compared experimentally by using radiochromic films. The results from both methods agreed to within 7%. Further, it is also inferred that for the dosimetry of endovascular brachytherapy, the film dosimetry may be considered adequate, even if the film calibration is time consuming and requires adequate dosimetric procedures.